Publications:  Dr Kirtiman Srivastava

Dakir E-H, Pickard A, SRIVASTAVA K, McCrudden CM, Gross SR, Lloyd S, Zhang S-D, Margariti A et al.(2018). The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer. Oncotarget vol. 9, (79) 34889-34910.

SRIVASTAVA K, Pickard A, Craig SG, Quinn GP, Lambe SM, James JA, McDade SS, McCance DJ(2018). ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers. Clinical Cancer Research

Bill MA, Srivastava K, Breen C, Butterworth KT, McMahon SJ, Prise KM, McCloskey KD(2017). Dual effects of radiation bystander signaling in urothelial cancer: purinergic-activation of apoptosis attenuates survival of urothelial cancer and normal urothelial cells. Oncotarget vol. 8, (57)

SRIVASTAVA K, Bayraktutan U(2017). Suppression of protein kinase C-α ameliorates hyperglycaemia-evoked in vitro cerebral barrier dysfunction. Stroke Research and Therapy vol. 2, (1)

SRIVASTAVA K, Pickard A, McDade S, McCance DJ(2017). p63 drives invasion in keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK signalling. Oncotarget vol. 8, (10) 16202-16219.

Rakkar K, SRIVASTAVA K, Bayraktutan U(2014). Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase. European Journal of Neuroscience vol. 39, (12)

Gibson CL, SRIVASTAVA K, Spring N, Bath PM, Bayraktutan U(2014). Inhibition of Rho-kinase protects cerebral barrier from ischemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions. Journal of Neurochemistry vol. 129, (5)

SRIVASTAVA K, Shao B, Bayraktutan U(2013). PKC-β exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathway. Journal of Cerebral Blood Flow and Metabolism vol. 33, (12)

Srivastava K, Bath PMW, Bayraktutan U(2012). Current Therapeutic Strategies to Mitigate the eNOS Dysfunction in Ischaemic Stroke. Cellular and Molecular Neurobiology vol. 32, (3) 319-336.

Allen C, Srivastava K, Bayraktutan U(2010). Small GTPase RhoA and Its Effector Rho Kinase Mediate Oxygen Glucose Deprivation-Evoked In Vitro Cerebral Barrier Dysfunction. Stroke vol. 41, (9) 2056-2063.